World's 1st inactivated COVID-19 vaccine produces Abs

Vaccines |  News | 0 Comment | 24 Jun, 2020

The Phase I/II clinical trials of the world's first inactivated COVID-19 vaccine, developed by Wuhan Institute of Biolog...Read more

Genexine enters human trial of COVID-19 vaccine

Vaccines |  News | 0 Comment | 24 Jun, 2020

South Korea based Genexine has announced that it is the first domestic pharmaceutical company to have been approved for ...Read more

Approved and effective vaccine against COVID-19 may not be available until 2021 summer: IHS Markit

Vaccines |  Opinion | By Gustav Ando | 0 Comment | 19 Jun, 2020

Ten COVID-19 vaccine candidates are currently in clinical trials (as of 4 June). These are listed in the below, in appro...Read more

Clover Biopharma initiates Ph 1 trial for COVID-19 vaccine

Vaccines |  News | 0 Comment | 22 Jun, 2020

Clover Biopharmaceuticals, headquartered in China, has announced that the first participants have been dosed in the Phas...Read more

Daiichi Sankyo to develop mRNA vaccine against COVID-19

Vaccines |  News | 0 Comment | 23 Jun, 2020

Daiichi Sankyo Company, Limited has announced its decision to develop a genetic (mRNA) vaccine for the novel corona viru...Read more

India's Serum Institute to play pivotal role in COVID-19 vaccines

Vaccines |  Analysis | 0 Comment | 18 Jun, 2020

Serum Institute of India (SII) is the world’s largest vaccine producer in terms of volume. SII is currently workin...Read more

“Beyond! Health Hack” invites Pharma-medical students to address flu-vaccine challenges

Vaccines |  News | 0 Comment | 18 Jun, 2020

In collaboration with the International Pharmaceutical Students’ Federation’s (IPSF) and the International F...Read more

Sinovac to initiate Ph 3 trial of COVID-19 vaccine

Vaccines |  News | 0 Comment | 16 Jun, 2020

China-based Sinovac Biotech Ltd. inked a clinical development collaboration agreement with a Brazilian producer of immun...Read more

BioNTech secures $112.55M for COVID-19 vaccine production

Vaccines |  News | 0 Comment | 16 Jun, 2020

Gernam firm BioNTech SE closed USD112.55 million debt financing agreement to support the development of the company&rsqu...Read more

Moderna advances Late-Stage development of mRNA-1273 Vaccine against COVID-19

Vaccines |  News | 0 Comment | 12 Jun, 2020

Moderna, Inc. announced on 11 June 2020 about progress on the late-stage development of mRNA-1273, the Company&rsqu...Read more

A novel method protects vaccines from heat degradation at RT for 3 yr

Vaccines |  News | 0 Comment | 11 Jun, 2020

Heat degradation of the proteins in vaccines render these expensive and precious biomedical products ineffective. Scient...Read more

MERS vaccine shows promise for COVID-19 vaccine development

Vaccines |  News | 0 Comment | 07 Jun, 2020

A recent Phase I clinical trial performed at the University Medical Center Hamburg-Eppendorf for a Middle East respirato...Read more

AstraZeneca Commits to 2 Billion Doses of COVID-19 Vaccine

Vaccines |  News | 0 Comment | 07 Jun, 2020

UK-based AstraZeneca and the University of Oxford partnered on the global development and distribution ...Read more

Novavax receives $60m from DOD to secure 10 million COVID-19 vaccine doses

Vaccines |  News | 0 Comment | 07 Jun, 2020

Novavax commenced Phase I clinical trial for their COVID-19 vaccine "NVX-CoV2373" a stable prefusion protein antige...Read more

INOVIO, IVI to start Ph 1/2 trials of COVID-19 vaccine in South Korea

Vaccines |  News | 0 Comment | 08 Jun, 2020

US based INOVIO, the International Vaccine Institute (IVI), and Seoul National University Hospital have announ...Read more

University of Queensland, CEPI and CSL partner for COVID-19 vaccine

Vaccines |  News | 0 Comment | 05 Jun, 2020

CEPI, the Coalition for Epidemic Preparedness Innovations, CSL and The University of Queensland (UQ) have announced that...Read more

CEPI awards Chikungunya vaccine "BBV87" $14.1 million

Vaccines |  News | 0 Comment | 03 Jun, 2020

The Coalition for Epidemic Preparedness Innovations (CEPI) on 3 June 2020 announced a new partnering agreement to advanc...Read more

Chikungunya Vaccine Candidate 'VLA1553' set to enter Phase 3 Study

Vaccines |  News | 0 Comment | 02 Jun, 2020

Chikungunya is considered to be a major public health threat by the World Health Organization. A speciality vaccine...Read more